Their study demonstrated that SPP1‐secreting tumour cells interacts with CD44‐expressing exhausted CD8+ T cells in situ, thereby reshaping the immune microenvironment and driving primary resistance.179. The gene discussed is SPP1; the disease is neoplasm.